Supply Chain Intelligence

BridgeBio Oncology Therapeutics, Inc. Supply Chain

BBOT supply chain intelligence for BridgeBio Oncology Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

BBOT ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

0Suppliers
0Customers
2Debt Items
5Related Chains

BridgeBio Oncology Therapeutics, Inc. Suppliers

No suppliers on recordBridgeBio Oncology Therapeutics, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

BridgeBio Oncology Therapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for BridgeBio Oncology Therapeutics, Inc..

BridgeBio Oncology Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
BBOT-DEBT-14223 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
BBOT-DEBT Debt stack $2.8M 90% Market cache reports total debt of $2.8M.

BridgeBio Oncology Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for BridgeBio Oncology Therapeutics, Inc..

BridgeBio Oncology Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
BBOT-OWNER-CORMORANT-ASSET-MANAGEMENT-LP Cormorant Asset Management, LP 90% 13F overlay lists Cormorant Asset Management, LP as top holder; 67 tracked holders.

BridgeBio Oncology Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
KKR KKR & Co. Inc. 100.00 2
SEPN Septerna, Inc. 100.00 2
OBDC Blue Owl Capital Corporation 100.00 2
BBIO BridgeBio Pharma, Inc. 38.88 1 ['receiving', 'spend']
BAYER BAYER 23.09 2
View BBOT supply chain intel →

Explore the full interactive supply chain map for BridgeBio Oncology Therapeutics, Inc..

Open BBOT supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map